Cannabis Policy
Recreational Cannabis Legalization Reduces Demand for Prescription Drugs, Study Finds
The researchers found that when states legalized cannabis, the volume of prescriptions given out for drugs related to managing pain, depression, anxiety, sleep, psychosis, and seizures all decreased significantly.
Cheaper is Not Always Better: The Risks of Illicit Mail-Order Marijuana
PPB Analytical's Ian Vand details the dangers of mail-order cannabis, and why consumers should stick to legal, tested products.
California’s Cannabis Regulator Confirms its New Director
Nicole Elliott was appointed by the California State Senate on March 30 following a unanimous vote of 34 senators.
Health Canada to Streamline its Cannabis Licensing Process
Canadian cannabis companies will soon be able to sell dried and fresh products during their initial licensing process.
Cannabis Legalization Netted US More Than $3.7 Billion in 2021
American states have generated more than $11.2 billion in tax revenue from state-legal recreational cannabis since sales began, according to a new report released this week by the Marijuana Policy Project.
US House of Representatives Passes MORE Act (Again)
The act was passed 220 votes to 204 on Friday, April 1.
UK’s Food Standards Agency Publishes List of Approved CBD Products
Any products that didn’t make the list should now be considered unauthorized and removed from shop shelves, according to regulators.
United States Pharmacopeia Prepares to Add CBD
A work-in-progress chemical profile of CBD, seen by Analytical Cannabis, details the cannabis compound’s properties, such as its typical retention time and the chromatographic procedures used to detect it.
US Congress to Vote on Cannabis Legalization Bill
The bill has been added to the official list of House bills to be considered for the week beginning March 28.
